JojoFinanceNotes
jojofinancePhD scientist || Over TEN years researching Infectious diseases and Immuno-oncology | Hunting the next Biotech breakthrough investments by breaking down the science.
| Platform |  | Pricing | Freemium | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 21 | Subscribers | Read | spatialplex.substack.com |
Curious about how many subscribers JojoFinanceNotes has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Read this before you take your next cup of coffee ☕️ [NEW RESEARCH]
I stumbled on this new research article, published in Nature communication, one of the highly prestigious medical journal out there. Very interesting, i though i should share with you all…
Why most drugs fail and what it costs
The biotech sector is structurally built on failure. Only roughly 9-12% of drug candidates entering Phase I ever reach market, this figure has barely budged over two decades despite exponential advances in biology and chemistry. For investo...
MBX Biosciences Inc (MBX)-Scientific deep dive for canvuparatide and pipeline assets
MBX utilizes its proprietary Precision Endocrine Peptides (PEP™) platform to engineer peptides that require less frequent dosing.
Multibagger (Idea 2), up 25%. Still has 100% upside potential
This could become THE highest grossing oncology drug.
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
PhD scientist || Over TEN years researching Infectious diseases and Immuno-oncology | Hunting the next Biotech breakthrough investments by breaking down the science.
Frequently Asked Questions
How can I access the email archive for JojoFinanceNotes?
You can find recent issues that have been published by JojoFinanceNotes on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does JojoFinanceNotes have?
To see how many people subscribe to JojoFinanceNotes, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in JojoFinanceNotes?
Newsletter advertising can be extremely effective when it's done right. Before you pitch JojoFinanceNotes as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like JojoFinanceNotes?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact JojoFinanceNotes using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to JojoFinanceNotes?
Scroll up to where it says Similar Newsletters to see other publications like JojoFinanceNotes. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact JojoFinanceNotes?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.